The present technology provides a novel approach for the treatment of muscle wasting in catabolic disorders associated with insulin resistance (e.g. type-2 diabetes, obesity, metabolic syndrome).
The present technology provides a novel approach for the treatment of muscle wasting in catabolic disorders associated with insulin resistance (e.g. type-2 diabetes, obesity, metabolic syndrome).